Gareth Worthington Email and Phone Number
Lucerne, LU, CH
Gareth Worthington's Location
Lucerne, Lucerne, Switzerland, Switzerland
About Gareth Worthington
Currently Head of Global Clearance focused on end-to-end MLR excellence at UCB, my mission is to revolutionize the speed to market for external stakeholder communications, including medical, commercial, corporate and patient engagement. My team and I have crafted transformative processes and leveraged innovative systems that have markedly improved the development and approval of critical content. Our collaborative efforts in cross-functional strategic partnerships exemplify my commitment to advancing medical science and patient care.This is poosible because with over two decades in the pharmaceutical industry, I've honed my expertise in strategic insight and global operations across medical affairs, marketing, competitive Intelligence and clinical development.Key competencies include:1. Provision of scientific direction relating to: medical or brand programme strategy (Global, Regional or Country); product development; medical, regulatory and official body guidance2. Business development and in-licence opportunity evaluation3. Brand strategy development and execution at a Global/International level 4. Inter-company, cross-functional, programme management to ensure successful product launch5. Launch Support & Best Practices Benchmarking6. Clinical development plan creation 7. Development and management of strategic communication, education and publication programmes for individual brands, franchises and entire portfolios 8. Strategic planning of evidence generation9. Competitive Intelligence and Monitoring10. Pipeline Analysis & Disease Landscape assessment11. Licensing and Acquisition Support 12. Scientific Engagement interactions with HCPs, KOLs13. Infrastructure and operational development, including personnel, systems (AI) and SOPs, AI deploymentI am also Director of Business Development at Vesuvian Media Group, CFO at DeTour and an author represented by GH Literary Management, NYC. Both my children are on the autism spectrum and I help expat parents navigate the system in Switzerland.
Gareth Worthington Work Experience Details
-
Snr. Director Global Content Design And Delivery VaccinesGskLucerne, Lu, Ch -
Global Head, Clearance - Medical And Commercial OperationsUcbLucerne, Switzerland -
Chief Financial OfficerDetour.Ch May 2024 - PresentDeTour is located in the idyllic town of Hausen am Albis, a place for creative minds from all areas of the art scene. On 380 square meters, we offer a bright, open work area, a pop-up shop with rentable shelves and clothes racks. An art gallery with a variety of works of art by different artists also runs through the entire location.Artists have the opportunity to show themselves, entrepreneurs can present their products and try things out, performers can present their shows, designers can create their collections. -
Global Head, Clearance - Medical And Commercial OperationsUcb Jan 2022 - PresentBrussels, BeResponsible for establishing a new Global Center of Excellence for review and dissemination of all external stakeholder-facing materials (disease, medical, product-related promotional, press, educational, training, market access and other materials) as well as leading the team, developing and overseeing global and regional clearance processes and technological systems for the review and approval of materials. Creation and deployment of transformative processes, ways of working and technology (including AI) for all of UCB with regards to the development and approval of commericial, medical, market access and other business crtitical content used externally.Center of Excellence• Standing up an organization to drive and foster UCB’s evolution in content lifecycle management focussing on co-creation, clearance global to local.• Create an organization that provides expertise and governance for the review and approval of all materials used externally, enabled through innovative technological operational and resource solutions.• Partner with IT to source, refine and deliver new and novel systems (e.g. GenAI, Veeva Vault, modular content platforms for omnichannel)• Development of Global and regional SOPs and execution resources across departments and stakeholders Infrastructure development • Cross functional workstreams for the re-development of how and where all content is created and approved from global to local within UCB., ways of working, systems, finance, SOPs, KPIs.• Harmonization of US and ROW content creation and clearance for the future.• Lead multiple workstreams across clinical, commercial, market access, pubs, sci comms, legal, regulatory, compliance, clearance, patient access and corp comms to deliver UCBs vision.
-
Founding Board MemberVesuvian Media Group, Inc. Jan 2014 - PresentI am a founding board member and Director of Business Development at Vesuvian Media. Vesuvian Media Group (VMG) is composed of industry veterans with decades of experience in entertainment, publishing, and representation.By creating our own ecosystem through Vesuvian Books and Vesuvian Entertainment, VMG captures the consumer from the moment the story is born. We want to touch the people who read books to escape and to feel. VMG takes the pioneers of the new publishing paradigm and gives their audience what they want—stories that will be remembered for generations to come—in print and on screen.And how do we know what’s popular before the market becomes saturated and moves on?Where it starts: boots on the ground, grassroots word-of-mouth from the readers. VMG is virtually on the “front lines.”Vesuvian Media group houses four publishing imprints:Vesuvian Books, Black Spot Books, Dropship Publishing, and Rosewind Books -
AuthorGandolfo Helin & Fountain Literary Management Sep 2013 - PresentI am an author of science-based thrillers represented by Gandolfo Helin & Fountain Literary, NYC.
-
Director, Global Scientific Content, Oncology Team LeadMsd Apr 2019 - Dec 2021Rahway, New Jersey, UsAs Director, Global Scientific Content (GSC) Oncology Team Lead, I oversee a team responsible for the development of Global Scientific Content plans for multiple indications related to pembrolizumab (HNCC, Melanoma, CNS, Biomarkers and Sarcoma). Beyond managing my team and signing off on all content plans, budgets and deliverables, my role is to continue to build the GSC and greater GMAC organizations through: SOP, policy, and Execution Resource development; cross functional strategic partnership; and creation of innovative solutions for the HCP--MSL interaction, and am responsible for the development and execution of external digital solutions for GMSA.Led a cross-functional team to envision, develop, and deploy www.merckmedicalportal.com an on-demand medical affairs portal. -
Director, Global Medical Affairs, Oncology PipelineServier Aug 2018 - May 2019Suresnes, Fr(Continuous role from Shire after buy out).Driving and involved in all aspects of medical and scientific input into the development of pipeline assets in oncology. Primary assets are Checkpoint inhibitors and allogeneic CAR-T.• Partner with Clinical Development, Commercial and Global Product Strategy to drive a unified franchise growth through:− Providing scientific and medical expertise to strategic recommendations − Pipeline Analysis & Disease Landscape − Competitive Intelligence & Monitoring − Marketing/Sales/Reimbursement Support Benchmarking − Launch Support & Best Practices Benchmarking − clinical development plan creation− Licensing and Acquisition Support − Scientific Engagement interactions with HCPs, KOLs • Represent Global Medical Affairs serving as a therapeutic area expert in scientific, strategic and tactical discussions and presentations with internal colleagues and external experts and investigators, payers, regulators• Creation of materials for medical affairs to use ion the field• Development of Medical Affairs / R and D driven steering committees and advisory boards to drive the pipeline development • Provide high quality scientific/clinical input and review of: disease strategy plans, publications, educational materials -
Director, Global Medical Affairs, Scientific Affairs & New Products Lead, Oncology FranchiseShire Apr 2016 - Aug 2018Tokyo, Jp, JpAs part of the leadership team, I drove and was involved in all aspects of medical, scientific and promotional activity for oncology globally. Scientific Affairs Lead• Design and implementation of the Global disease area medical plans, with the VP & Global Head Franchise Oncology MA, and in coordination with the Global Franchise Leads for Solid and Liquid Tumors. • Leadership for the execution of Shire-sponsored medical affairs trials, and evaluate and support of investigator-initiated trials. • Provide high quality scientific/clinical input and review of: disease strategy plans, publications, educational materials, webcasts, IIR protocols, Commercial Brand plans, Scientific educational grant requests and patient advocacy grant requests• Represent Global Medical Affairs serving as a therapeutic area expert in scientific, strategic and tactical discussions and presentations with internal colleagues and external experts and investigators, payers, regulators.• Lead/support Medical Affairs cross-functional groupsNew Products Lead• Partner with Clinical Development, Commercial and Global Product Strategy to drive a unified franchise growth through pipeline optimisation, in-line life cycle management, in-licensing opportunities (CAR-T; checkpoint Inhibitors), clinical development plan creation.− Providing scientific and medical expertise to strategic recommendations − Pipeline Analysis & Disease Landscape − Competitive Intelligence & Monitoring − Marketing/Sales/Reimbursement Support Benchmarking − Launch Support & Best Practices Benchmarking − Clinical development plan creation• Licensing and Acquisition Support • Scientific Engagement interactions with HCPs, KOLs -
Acting Managing Director/Deputy Head EuropePennside Partners Apr 2015 - Apr 2016Wyomissing, Pa, UsI Managed all aspects of running the Pennside Partners EU business unit.I was primarily responsible driving strategic business intelligence projects for the pharmaceutical industry across a variety of therapeutic areas. I combined this information with my years of industry experience to provide market and competitor analysis, and make strategic recommendations that proactively drove informed commercial and scientific business decisions.Key activities included, but were not limited to:• Leading my team of analysts, project managers, medics, pharmacists, and business consultants in projects, comprising:− Competitive Intelligence & Monitoring− Pipeline Analysis & Disease Landscape− Marketing/Sales/Reimbursement Support Benchmarking− Launch Support & Best Practices Benchmarking− Customer Facing & New Commercial Models− Licensing and Acquisition Support− Strategy Workshops / War Games• Driving the continued growth of the European office• Providing scientific and medical expertise to strategic recommendations in medical and commercial endeavors• Driving excellence in external Scientific Engagement interactions with HCPs, Patients, Payors and Regulators• Co-ordinating global intelligence projects between the USA and EU offices• Building a strong external network of key stakeholders• Internal change management to bring Pennside to implement new, more efficient, systems and process -
Director, Scientific Affairs, Oncology, Asia & Med Comm Lead, Oncology, InternationalGsk May 2013 - Mar 2015Brentford, Middlesex, GbDirector, scientific affairs, Oncology, AsiaI was involved in all aspects of medical, scientific and promotional activity in the Asia and Asia Pacific region for two oncology products.Key responsibilities included:• Drive the medical strategy for panitumumab in Asia, including the establishment of molecular diagnositic capabilities on the region • Co-develop the brand plan for panitumumab in Asia• Drive excellence in external Scientific Engagemento interactions with HCPs, Patients, Payors and Regulators• Generation and execution of regional scientific engagement activities• Approving key promotional, scientific engagement, and regulatory materials created for, and by, the local operating companies (affiliates)• Support evidence generation requirements• Ensuring appropriate medical governance, including leading the management of product-related issues/crises with potential impact on patient safety• Garnering buy-in and commitment from Area Medical Directors and LOC Medical Directors of major markets in support of agreed medical strategies• Internal education on key scientific/medical data relating to GSK and competitor productsDirector, medical communications, Oncology, InternationalThis role, reporting to the International medical lead, required an oversight of all oncology assets across Europe, Lat Am, Russia & CIS, MEA and Asia Pacific.Key responsibilities included:• Generation of an over-arching medical communications plan for International • Generation of internal communications to both LOC and senior management on key activities – both internal and external• Support of key scientific engagement activities in the International region, from agenda and content development, to onsite delivery• Drive select high-profile scientific activities, including GSKs participation in the UICC’s World Cancer Leaders’ Summit.• Be a member of the Developing Countries Market Access Team• Lead Global ideation sub-team to build HCP engagement strategies
-
Senior Manager Scientific Affairs, Oncology, International RegionAmgen Jul 2010 - May 2013Thousand Oaks, Ca, UsI was a Scientific Affairs Senior Manager in the International region. In this role I was part of the Vectibix (panitumumab), Aranesp (darbepoetin alpha) Oncology, and AMG102 (rilotumumab) and T-VEC (talimogene laherparepvec) brand teams. My responsibilities included (but were not limited to):• Providing leadership and expertise in publications planning and execution for my product International Medical Teams and affiliate countries • Driving the Global Task Force on Personalised Medicine in Oncology; integrating and co-ordinating medical, commercial, corp comms, gov affairs, sci affairs• Shaping and driving the overall medical and brand strategy and respective tactical plans as a key member of the International Medical Teams and International Brand Teams for the aforementioned products• Leveraging scientific and strategic knowledge and the position of ‘internal interface’ to: o drive key relationships and business initiatives with various internal stakeholders as well as external partners and vendors Medical communications (Global/IHQ) Health economics (Global/IHQ) Clinical research management (Global/IHQ) Biostatistics (Global/IHQ) Project management (Global/IHQ) Medical directors (Global/IHQ) Marketing (Global/IHQ) Amgen affiliate offices (EU, Australia, NZ, emerging markets) Key opinion leaders Vendors.• Driving scientific intelligence gathering at key congresses throughout the year o Including delivery of strategically-focussed reports for Global, International and affiliate colleagues.• Driving and helping to develop internal education, for all affiliate countries regarding publication SOPs and best practice, including leading the development of cross-brand authorship policy and procedures. -
Global Medical Lead, Metabolic ControlDanone Sep 2009 - Jul 2010Paris, FrAs Global Medical Lead, I provided medical/scientific direction to drive the global advancement of nutritional therapy in inborn errors of metabolism.Nutricia Advanced Medical Nutrition is the medical division of Danone. Nutricia comprises 5 categories all of which specialise in special foods for medical purposes. Primarily, this involves developing medical foods that lack particular offending metabolites. I was the Global Medical Manager for the category that deals with patients who have inborn errors of metabolism (>30 individual diseases). I managed all medical affairs for the metabolic control category on a global scale. This included, but was not limited to:-Leading the medical/scientific direction of the global franchise brand plan-Global responsibility for supporting the expansion of mandatory programmes to screen newborns for inborn errors of metabolism-Global medical lead for new product development-Key Thought Leader relationship development and management-Strategic medical communications and publications planning and execution-Vendor management-Development and review of global marketing/brand and medical materials-Global website development-Internal medical knowledge training for country colleagues-Country specific business reviews-Competitor intelligence analysis -
Senior Medical Communications SpecialistKnowledgepoint360 Apr 2005 - Sep 2009GeoMed are one of 13 medical communication agencies as part of the KnowledgePoint360Group – one of the largest medical communications agencies in the world.This role involved all aspects of full service medical communications, from writing abstracts and posters to strategic publication and communication planning and KTL management. New business development was also a key part of my role here.
-
Junior Management ConsultantAugmentis Sep 2004 - Apr 2005Gb
Gareth Worthington Skills
Oncology
Pharmaceutical Industry
Cancer
Biotechnology
Medical Writing
Medical Affairs
Market Access
Clinical Trials
Clinical Development
Clinical Research
Marketing Strategy
Life Sciences
Pharmaceutical Sales
Therapeutic Areas
Hematology
Infectious Diseases
Health Economics
Healthcare
Immunology
Drug Development
Diabetes
Cardiology
Medical Devices
Competitive Intelligence
Medical Education
Team Leadership
Training
Stakeholder Workshops
Medical Communications
Lifesciences
Rheumatoid Arthritis
Hypertension
Psoriasis
Breast Cancer
Prostate Cancer
Type 2 Diabetes
Ulcerative Colitis
Pharmaceuticals
Publication Planning
Gastroenterology
Dermatology
Rheumatology
Scientific Writing
Endocrinology
Brand Strategy
Medical Strategy
Infrastructure Planning
Creative Problem Solving
Alliance Management
Gareth Worthington Education Details
-
Quantic School Of Business And TechnologyExecutive Master Of Business Administration - Emba -
Accreditation Council For Medical AffairsMedical Affairs
-
The University Of ManchesterBiology
-
University Of PlymouthBiology
Frequently Asked Questions about Gareth Worthington
What company does Gareth Worthington work for?
Gareth Worthington works for Gsk
What is Gareth Worthington's role at the current company?
Gareth Worthington's current role is Snr. Director Global Content Design and Delivery Vaccines.
What schools did Gareth Worthington attend?
Gareth Worthington attended Quantic School Of Business And Technology, Accreditation Council For Medical Affairs, The University Of Manchester, University Of Plymouth.
What are some of Gareth Worthington's interests?
Gareth Worthington has interest in Education, Environment, Science And Technology, Disaster And Humanitarian Relief, Animal Welfare.
What skills is Gareth Worthington known for?
Gareth Worthington has skills like Oncology, Pharmaceutical Industry, Cancer, Biotechnology, Medical Writing, Medical Affairs, Market Access, Clinical Trials, Clinical Development, Clinical Research, Marketing Strategy, Life Sciences.
Who are Gareth Worthington's colleagues?
Gareth Worthington's colleagues are Arpit Dixit.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial